Sodium-glucose cotransporter 2 inhibitor for the treatment of diabetic nephropathy
As one of the most common microvascular complications of diabetes mellitus, diabetic nephropathy（DN）is a common cause of end-stage renal disease（ESRD）.Sodium-glucose cotransporter 2（SGLT-2）inhibitor, a new type of hypoglycemic agent, may effectively lower blood glucose, improve renal hyperfiltration...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2021-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57905330&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|